IDT 0.00% 12.5¢ idt australia limited

Ann: Generics Sales Update, page-7

  1. 2,140 Posts.
    lightbulb Created with Sketch. 594
    Interesting that IDT's market cap is still less than $40m considering the potential sales of Temozolomide alone ...

    The original (Temodar) had sales, before the parent exipired in 2013, of over $800M !
    http://www.fiercepharma.com/special-report/temodar

    The initial stock quantities manufactured for Mayne had been expected to satisfy demand until mid-2017 but uptake has been better than anticipated, demanding earlier than expected replenishment - for the higher dose strengths of 180mg and 250mg.

    So that's only Temozolomide.
    There is also a minimum of 6 further products "that should attain marketable status this calendar year".  

    Kinda surprising that the s/p is less than 20c
 
watchlist Created with Sketch. Add IDT (ASX) to my watchlist
(20min delay)
Last
12.5¢
Change
0.000(0.00%)
Mkt cap ! $53.69M
Open High Low Value Volume
12.5¢ 13.0¢ 12.5¢ $14.53K 115.3K

Buyers (Bids)

No. Vol. Price($)
2 492349 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.0¢ 157806 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
IDT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.